Real-world evidence study finds no new-onset diabetes or drug-related hyperglycemia in Pompe disease patients treated with avalglucosidase alfa

Avalglucosidase alfa therapy for Pompe disease is diluted in dextrose 5% solution in water (D5W) for infusion, which raises questions about the potential for hyperglycemia or worsening diabetes. Using United States insurance claims data, we assessed the impact of biweekly infusions on hyperglycemia,...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Alexandra Dumitriu, Ann Lucas, Raffaella Colzani
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2024-03-01
סדרה:	Molecular Genetics and Metabolism Reports
נושאים:	Avalglucosidase alfa Pompe disease Hyperglycemia Diabetes mellitus Insulin resistance Prediabetes
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S221442692400017X
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!